US FDA Approves Outlook Therapeutics' Eye Disease Drug

Published Date: 28 Jul 2026

Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for ⁠a type of eye disease that can cause vision loss.

Read Full News

Latest News

Hospital Doctors Plan 24-Hour Walkout in Victoria, Australia

The walkouts are the next stage of the doctors’ effort to improve what they call long hours and poor working conditions.

West Nile Virus Infections Cause Three Deaths in the Netherlands

Three people in the Netherlands have died from ⁠an infection caused by the West Nile virus in recent weeks, ⁠the country's public health institution RIVM said on Thursday,...

Chronic Low Back Pain: Do Lumbar Braces Deliver?

Lumbar braces modestly ease chronic low back pain when paired with NSAIDs, but low-certainty evidence and missing safety data means their role in routine care remains unclear.

Bangladesh Fights World's Worst Measles Outbreak as Vaccination Gaps Fuel Spread

Bangladesh, which once came close to eliminating measles, is facing its worst outbreak on record, with 999 suspected and confirmed measles-related deaths reported since...

Switching Dialysis Modalities Ups Mortality in Older Adults

Switching from peritoneal dialysis to hemodialysis is independently associated with increased mortality risk in adults aged 80 years or older.

Shifting the Weight-Loss Focus: More Than Pounds Lost

Every new weight-loss medication seems to promise a greater quantity of weight loss, but growing numbers of experts say it’s crucial to balance quality with quantity of weight loss.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

The walkouts are the next stage of the doctors’ effort to improve what they call long hours and poor working conditions.

Three people in the Netherlands have died from ⁠an infection caused by the West Nile virus in recent weeks, ⁠the country's public health institution RIVM said on Thursday,...

Lumbar braces modestly ease chronic low back pain when paired with NSAIDs, but low-certainty evidence and missing safety data means their role in routine care remains unclear.

Bangladesh, which once came close to eliminating measles, is facing its worst outbreak on record, with 999 suspected and confirmed measles-related deaths reported since...

Switching from peritoneal dialysis to hemodialysis is independently associated with increased mortality risk in adults aged 80 years or older.

Every new weight-loss medication seems to promise a greater quantity of weight loss, but growing numbers of experts say it’s crucial to balance quality with quantity of weight loss.

News All Time

Ultrasound Expands Options for Chest Lesion Biopsy

A radiation-sparing procedure shows a safe and effective diagnostic potential.

Irish Health Service Operator Fined for Storing Data in Disused Bathroom, Turf Shed

Ireland's health service operator was fined a record amount for an Irish public body by the country's data regulator ⁠for storing medical records in "profound disarray" in...

How to Differentiate the Major Subtypes of ILD

The definitions of interstitial lung disease subtypes have undergone major revisions, encompassing clinical, radiologic, and histologic findings, as well as a few new categories.
HTTP error: 503HTTP error: 503

UnitedHealthcare to Drop Prior Authorization Requirements for Range Of Conditions From Oct. 1

UnitedHealth's insurance unit said on Tuesday that a broad range of conditions will no ⁠longer need prior approval, effective October 1, as it aims to eliminate prior...
HTTP error: 503

What to Know About ‘Musculoskeletal Syndrome of Menopause’

Is new joint pain in perimenopause simple arthralgia or underlying inflammatory arthritis? Learn key diagnostic steps, seronegative RA risks, and hormone replacement therapy insights.
HTTP error: 503

MRI Pattern May Forecast MCI to Dementia Timeline

An MRI-defined pattern of cortical atrophy may help identify patients with early-onset Alzheimer’s disease at risk for more rapid progression from MCI to dementia.

At-Home Lecanemab: What Does It Mean for Alzheimer’s Care?

At-home subcutaneous lecanemab may ease the burden of frequent infusions, but clinicians still face key questions about patient selection, training, ARIA monitoring, adherence, and access.
HTTP error: 503

Early Oseltamivir Tied to Lower Hospitalization Risk in Flu

Among adult veterans, oseltamivir treatment initiated within 6 hours of influenza diagnosis is associated with a reduced risk for hospitalization.

AI Outperforms Gene Sequencing for Lung Nodule Triage

Interpret findings with caution, but AI-based radiomics may help curb unnecessary procedures.
HTTP error: 503HTTP error: 503

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot